GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems.
Our diverse portfolio consists of vaccines, specialty medicines, and general medicines.
Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges.
We are seeking a dynamic and innovative Omnichannel Marketing Excellence Manager Customer Experience (m/f/d) - limited contract unil February 2027 to drive the development, deployment, and optimization of AI and technology-enabled omnichannel solutions. This role offers an exciting opportunity to shape the future of content creation and delivery at GSK, leveraging cutting-edge technology and AI to maximize impact globally.
Responsibilities:
1. Lead the co-creation and deployment of AI and tech-enabled content products, including Content Multiplier, Modular Content, and AI-powered Medical, Legal, and Regulatory (MLR) review tools.
2. Collaborate with cross-functional global teams to define requirements, prioritize features, and align with business goals.
3. Champion technology adoption and drive training initiatives for effective tool usage.
4. Act as a trusted advisor to business leaders, identifying opportunities to address content creation, management, and distribution challenges.
5. Build and maintain strong partnerships with external vendors to deliver AI-enabled content solutions.
6. Monitor and measure the effectiveness of deployed content products, driving continuous improvement and optimization.
7. Stay ahead of industry trends, emerging technologies, and best practices to introduce innovative approaches proactively.
Qualifications & Skills:
8. Technical literacy and familiarity with modern tech stacks (e.g., SFMC,GraphQL, headless CMS like Git workflows).
9. Experience with UX design tools (e.g., Figma/Sketch), content design systems, and component libraries.
10. Knowledge of localization platforms (e.g., Smartling, Transifex, Lokalise) and translation pipeline integration.
11. Basic familiarity with AI/LLM applications for content generation, review, and governance, including implementing quality guardrails.
12. Strategic thinker with the ability to balance long-term vision and pragmatic delivery.
13. Strong collaboration skills across Product, Design, Engineering, and Commercial functions.
Preferred Qualifications & Skills:
14. Domain expertise in healthcare, life sciences, pharma, or regulated industries.
15. Experience implementing content design systems and componentized content at scale.
16. Familiarity with conversational UX (e.g., chatbots, voice).
17. Prior experience building content teams in global/matrixed organizations.
18. German proficiency would be benefinicial
#LI-GSK
Why GSK?
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.